Philadelphia, PA (September 17, 2015) – Enclara Pharmacia, the nation’s leading provider of comprehensive pharmacy management services to the hospice industry, has appointed Matthew Sudduth its new Executive Vice President and Chief Financial Officer. Matt will be leading the Finance and Information Technology organizations at Enclara, charged with developing these critical functions to help Enclara reach it’s near and long term strategic goals.
“Matt’s unique combination of strong business and financial experience, along with demonstrated success in leading a complex integration, will enable him to make a significant contribution to the success of Enclara as a senior executive. We looked to bring the best financial leadership talent to Enclara and we think we found that in Matt,” said Andy Horowitz, CEO of Enclara Pharmacia.
Sudduth joins Enclara Pharmacia from Thermo Fisher Scientific, where for 11 years he held a number of senior finance leadership roles, including Divisional CFO of the BioPharma Services and the Anatomical Pathology divisions. Most recently, Sudduth helped lead the successful integration of Life Technologies, a recent acquisition, into Thermo Fisher. Prior to Thermo Fisher, Sudduth held positions at GenTek, Inc. and Latona Associates. Matt holds a B.S. from Bates College and an MBA from Columbia Business School. Matt, his wife, and two daughters reside in Philadelphia.
Matt joins The Enclara Pharmacia leadership team, who are dedicated to developing a cohesive and cost-effective program that results in the best experience possible for hospices and patients facing end-of-life issues. Members of the team have grown up in hospice as owners, operators, and practitioners so we understand the challenges hospices face and are uniquely qualified to provide timely, cost-effective solutions.
About Enclara Pharmacia
Enclara Pharmacia is a national full-service mail order and PBM supplier of medications and clinical services developed specifically for the hospice and palliative care industry. Enclara services over 500 customers and 85,000 patients in 48 states, helping to reduce pharmacy costs through a clinically driven model that enables home delivery of pharmaceuticals, as well as access to a network of over 65,000 retail pharmacies, including our own automated fulfillment pharmacies, and institutional pharmacies.